U.S. Banks Stock News

On March 23, 2026, Piper Sandler Companies filed an amendment to its Delaware certificate of incorporation to complete a four-for-one forward stock split of its common stock, maintain the par value at US$0.01, increase authorized shares from 100,000,000 to 400,000,000, and begin split-adjusted trading on March 24 under a new CUSIP. This move materially increases the share count and lowers the price per share, which can broaden investor accessibility and enhance trading liquidity without...

Wondering whether McKesson at around US$860 a share still offers value or is pricing in most of its strengths already? This breakdown will help you frame that question clearly. The stock has seen a 2.9% decline over the last week and a 10.7% decline over the last month, although it still sits on a 4.5% return year to date and a 29.3% return over the past year. Recent coverage has focused on McKesson's role across healthcare distribution and services, as investors weigh how sector wide trends...

Millrose Properties (NYSE:MRP) has amended its credit facility, expanding it into a larger unsecured structure. The company is transitioning from a secured facility to an unsecured framework with added term loan capacity. This shift represents a material change in Millrose's capital structure and liquidity profile. For a real estate focused business like Millrose Properties, access to flexible credit can be just as important as the properties it owns. The move toward an unsecured facility...

MSCI (MSCI) has been drawing attention after a period of weaker share performance, with the stock showing negative returns over the past month and past 3 months despite sizeable revenue and net income levels. See our latest analysis for MSCI. The recent weakness, including a 1 day share price return of 2.11% and a 90 day share price return of 10.53%, contrasts with a 5 year total shareholder return of 28.84%. This indicates that momentum has been fading after a longer period of value...

ASGN stock reaction and recent performance ASGN (ASGN) has drawn attention after recent share price moves, with the stock closing at $37.56 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for ASGN. That 5.9% one day share price decline sits within a wider losing stretch, with a 30 day share price return of 8.5% and a 90 day share price return of 24.9%. At the same time, the 1 year total shareholder return of 40.4% and 5 year total shareholder...

JFrog (FROG) is back in focus after UBS upgraded the stock, pointing to the company’s rapid handling of a recent supply chain attack and its new AI security offerings, including the JFrog MCP Registry. See our latest analysis for JFrog. Despite the upgrade-driven jump, JFrog’s recent share price performance has been mixed, with an 11.8% 1 month share price return contrasted against a 35.25% 3 month share price decline. Its 1 year total shareholder return of 35.42% suggests momentum over a...

Recent disruptions to shipping through the Strait of Hormuz have tightened global fertilizer supply, pushing up prices and boosting prospects for nitrogen-focused producers such as CVR Partners. Analysts at Bank of America have highlighted that these elevated earnings for fertilizer makers may be short-lived, as industry conditions typically cycle back toward more normal levels once geopolitical tensions ease. We’ll now consider how the prospect of short-term windfall profits from tighter...

If you are wondering whether Merchants Bancorp at around US$42.27 is still offering value or edging toward the expensive side, you are not alone. The stock has returned 2.6% over the last week, 27.4% year to date and 15.4% over the past year, with a 2.4% decline across the last 30 days adding a bit of extra uncertainty for anyone thinking about entry points. Recent attention around Merchants Bancorp has centered on its position in the diversified financials space and how investors are...

Event context and recent performance Saul Centers (BFS) has attracted fresh attention after recent share price moves. The stock closed at $32.34, with a 1-day return of a 1% decline, a flat performance over the week, and a 5.8% decline over the past month. See our latest analysis for Saul Centers. That recent 5.8% one month share price decline sits against a modest 2.5% 90 day share price return and a 2.5% year to date share price gain. The 1 year total shareholder return is slightly...

What recent performance says about Tapestry (TPR) Tapestry (TPR) has seen its share price slip about 1.8% over the past day and roughly 1.4% over the past week, while the stock is down around 11.5% over the past month. Despite these shorter term declines, Tapestry shows a positive return of about 5.7% over the past 3 months and 7.6% year to date, with a 1 year total return near 100.5%. See our latest analysis for Tapestry. Recent trading has cooled after a strong run, with the latest share...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Steel...

Recent commentary on Ellington Financial (EFC) focuses on how its hedging, diversified portfolio, financing sources, and relatively low leverage are helping it manage mortgage market volatility and ongoing loan origination activity. See our latest analysis for Ellington Financial. At a share price of US$11.55, Ellington Financial has seen a 2.21% 7 day share price gain, but its 30 day and year to date share price returns of 7.75% and 15.57% declines suggest momentum has cooled, even as the 3...

Stock performance snapshot and recent context United Community Banks (UCB) stock has seen mixed recent performance, with a 1 day return of about a 1.3% decline, a 7 day gain of 2.7%, and a month return of an 8.1% decline as of the latest close. See our latest analysis for United Community Banks. At around $30.93 per share, the recent 8.1% 30 day share price decline contrasts with a 14.9% 1 year total shareholder return. This suggests shorter term caution, while longer term investors have...

Investors may be wondering whether Materion, at around US$141 a share, still offers value or if most of the potential upside has already been priced in. The stock has moved sharply, with a 7.1% gain over the last week, a 12.5% decline over the last month, and returns of 10.0% year to date and 70.4% over the past year. These swings have kept the stock on many investors' watchlists, as price action alone does not explain what is driving sentiment. Recent coverage has focused on how the...

If you are wondering whether Plains GP Holdings at around US$24.46 still offers value or if most of the opportunity is already priced in, the starting point is to look closely at what the market is paying for its fundamentals. The stock has delivered returns of 3.3% over the past week, 10.2% over the last month, 26.0% year to date and 23.4% over the past year, with a very large 3 year gain and a 272.0% return over 5 years that may shape current expectations and risk views. Recent headlines...

Pentair (NYSE:PNR) announced the retirement of long-serving Chair David A. Jones after more than two decades on the Board and eight years as Chair. T. Michael Glenn, an independent director with extensive board experience, has been appointed as the new Chair. The transition marks a planned change in board leadership and governance oversight at Pentair. Pentair focuses on water treatment and fluid management solutions, an area that sits at the intersection of infrastructure, sustainability...

Graco recently reported a past quarter with revenues up 8.1% year on year and earnings exceeding analysts’ EBITDA expectations, reflecting solid near‑term execution. However, flat sales over the last two years, declining earnings per share, and shrinking returns on capital have raised concerns about longer‑term growth and profitability. We’ll now explore how these signs of muted long‑term growth, despite a recent earnings beat, may influence Graco’s broader investment narrative. Outshine the...

Earlier this week, a Los Angeles jury ruled that Alphabet’s Google and Meta designed YouTube and Instagram in ways that contributed to a young woman’s social media addiction and mental health harms, awarding a combined US$6.00 million in compensatory and punitive damages and finding both companies failed to adequately warn users about these risks. This verdict targets the core design of engagement-driving features rather than user content, potentially reshaping legal protections under...

Earlier in 2026, Zimmer Biomet was honored with three Healthcare Asia Medtech Awards for its iodine-treated hip implants, WalkAI recovery platform, and surgeon engagement initiatives, underscoring its focus on orthopedic and digital health innovation. The recognition for WalkAI, which applies artificial intelligence to monitor knee replacement recovery and enable earlier clinical intervention, highlights how Zimmer Biomet is pairing traditional implants with data-driven tools to support...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Earlier this week, McCormick expanded its 2026 Flavor of the Year campaign by rolling out Black Currant seasoning and finishing sugar, and by hosting Sensoria: The Black Currant Experience in New York, a multisensory event that brought the flavor trend to consumers and culinary professionals. This push around Black Currant underlines how McCormick uses trend-driven product innovation and immersive brand experiences to deepen engagement with both home cooks and foodservice partners. Next,...

For readers wondering whether Lockheed Martin at around US$615 per share still offers value, or if most of the easy gains are behind it, this article walks through what the current price may be implying. The stock has given investors a 23.9% return year to date and 43.3% over the last year, with a 90.0% return across five years. However, the past 7 days and 30 days show declines of 1.8% and 4.9% respectively. Recent headlines have focused on Lockheed Martin's role in global defense programs...

On 24 March 2026, Medtronic announced a distribution agreement with Merit Medical Systems to offer ViaVerte, an FDA-cleared, minimally invasive basivertebral nerve ablation system for chronic vertebrogenic lower back pain, extending an existing supply relationship between the two companies. This agreement gives Merit access to Medtronic’s broad pain management distribution network, potentially increasing physician adoption of ViaVerte and reinforcing Merit's position in outpatient spine...

In March 2026, Genesis Energy and a current board member were sued in Harris County State Court for alleged repeated sexual assaults against a Jane Doe, with the complaint seeking US$50,000,000 in compensatory and punitive damages. The involvement of a sitting director and high-profile litigator Tony Buzbee, known for very large sexual assault outcomes, raises important questions about Genesis Energy’s governance and reputational risk controls. Against this backdrop, we’ll explore how the...